Tirzepatide provides a variety of benefits, including significant weight loss, better blood sugar regulation, and a reduced risk of heart disease and kidney complications
The "maintained improvements" group (approximately 30-40% of users) reports substantial benefit retention 6-12 months post-discontinuation, typically characterized by users who completed 6+ month treatment courses using adequate concentrations (1-2% GHK-Cu), maintained consistent application patterns, addressed underlying skin damage during treatment allowing structural improvements, optimized complementary skincare including sun protection and moisturization, maintained healthy lifestyle supporting collagen synthesis including adequate protein intake and sleep, and possessed favorable genetics for collagen production and skin aging resistance
Without the transcript, we are working from pattern recognition in this category, and this creator's hashtag choice places them squarely in that ecosystem
The clinician said: MOTS-C is something that helps provide more stress resilience and better health to your mitochondria to be able to produce more energy cells so the direct net effect for you would be reduced insulin resistance, better energy production in the form of [the energy molecule] ATP, and the net result of that is basically reduce visceral fat. The MHRA said it was investigating whether the claims made by the clinician were medicinal
This groundbreaking treatment has shown significant results in clinical trials, offering a promising solution for those struggling with weight management
It is important to assess for gut dysbiosis or imbalances in the gut microbiome
